Merck (NYSE: MRK) stock has been a longtime winner for investors, returning 72% in the past five years. A major factor in ...

We recently compiled a list of the 12 Best Blue Chip Stocks To Invest In According to Short Sellers. In this article, we are ...

Merck’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value. Merck ...

MRK and Daiichi Sankyo's patritumab deruxtecan shows statistically significant progression-free survival improvement in previously treated EGFR-mutated NSCLC.

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

Merck's Keytruda scored two important victories in women's cancer, according to presentations Sunday at the ESMO meeting.

In this photo illustration, the Merck & Co., Inc. logo seen displayed on a ... [+] tablet. (Photo Illustration by Igor ...

We recently compiled a list of the 10 Best Defensive Stocks According ... The FDA’s late March approval of pulmonary arterial hypertension drug sotatercept, also drove share gains. We retain ...

We recently compiled a list of the 7 Best Stocks for Beginners ... The FDA’s late March approval of pulmonary arterial hypertension drug sotatercept, also drove share gains. We retain conviction as ...

We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are going to take a look at where Merck & Co., Inc ... The market for cancer drugs alone was estimated ...

Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp. (COST), Merck & Co., Inc ... competition for several drugs and rising competitive ...